Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ECONAZOLE NITRATE CRS (100 MG)

ECONAZOLE NITRATE CRS (100 MG)

24169-02-6

DISCOVER
EICOSAPENTAENOIC ACID ETHYL ESTER  CRS (200 MG)

EICOSAPENTAENOIC ACID ETHYL ESTER CRS (200 MG)

73310-10-8

DISCOVER
EMETINE HYDROCHLORIDE CRS (15MG)

EMETINE HYDROCHLORIDE CRS (15MG)

316-42-7

DISCOVER
ENALAPRIL MALEATE CRS (15 MG)

ENALAPRIL MALEATE CRS (15 MG)

76095-16-4

DISCOVER
ENALAPRIL FOR SYSTEM SUITABILITY CRS (10 MG)

ENALAPRIL FOR SYSTEM SUITABILITY CRS (10 MG)

76095-16-4

DISCOVER
Erythromycine

Erythromycine

114-07-8

DISCOVER
ENDOTOXIN STANDARD BRP (10 MG)

ENDOTOXIN STANDARD BRP (10 MG)

67924-63-4

DISCOVER
Erythromycine A 2H2O

Erythromycine A 2H2O

59319-72-1

DISCOVER
Estradiol-17-alpha

Estradiol-17-alpha

57-91-0

DISCOVER
ENOXAPARIN SODIUM CRS (120 MG)

ENOXAPARIN SODIUM CRS (120 MG)

01/08/9041

DISCOVER
ENOXOLONE CRS (220 MG)

ENOXOLONE CRS (220 MG)

471-53-4

DISCOVER
Estradiol-17-beta

Estradiol-17-beta

50-28-2

DISCOVER